Objective: Three-dimensional image fusion of preoperative computed tomography (CT) angiography with fluoroscopy using intraoperative noncontrast cone-beam CT (CBCT) has been shown to improve endovascular procedures by reducing procedure length, radiation dose, and contrast media volume. However, patients with a contraindication to CT angiography (renal insufficiency, iodinated contrast allergy) may not benefit from this image fusion technique. The primary objective of this study was to evaluate the feasibility of magnetic resonance angiography (MRA) and fluoroscopy image fusion using noncontrast CBCT as a guidance tool during complex endovascular aortic procedures, especially in patients with renal insufficiency.
Preoperative three-dimensional (3D) image fusion with intraoperative fluoroscopy has become more and more practical and used to guide complex endovascular aortic procedures. Typically, image fusion of preoperative 3D image data sets with fluoroscopy involves one of the following techniques:
1. Image-based 3D-3D registration of the preoperative 3D data set with an intraoperative noncontrast cone-beam computed tomography (CBCT) data set, followed by machine or calibration-based twodimensional (2D)-3D registration to fluoroscopy, or 2. Direct image-based 2D-3D registration, where two C-arm fluoroscopy images acquired at least 30 apart are used to coregister the preoperative 3D data set.
Various studies have reported the incremental value of image fusion during endovascular aortic procedures with a significant reduction of procedure length, radiation dose, and injected contrast agent volume. [1] [2] [3] [4] [5] [6] However, most of these studies report image coregistration between preoperative multislice CT angiography (CTA) and intraoperative CBCT, with bony landmarks used to optimize the image registration process. Because of the high risk of tubular necrosis, CTA with iodinated contrast injection is contraindicated in patients with severe renal insufficiency (glomerular filtration rate [GFR] <30 mL/min/1.73 m 2 ) and should be avoided in those with moderate renal insufficiency (GFR between 30 and 60 mL/min/1.73 m 2 ). 7 One of the main advantages of image fusion techniques includes reduction in the use of the iodinated contrast agent, which would be very beneficial, especially in these patients with renal insufficiency. Contrast-enhanced magnetic resonance (MR) angiography (MRA) is an alternative imaging technique to CTA and is performed safely, even in patients with end-stage renal disease, using an iron-based contrast agent, ferumoxytol (Feraheme; AMAG Pharmaceuticals, Waltham, Mass). 8, 9 Such MRA images acquired in 3D
format could be used as a preoperative imaging data set for further intraoperative image fusion guidance. Our literature search shows that few reports on gadolinium-enhanced MRA image fusion technique for endovascular aortoiliac procedures have been published. [10] [11] [12] The primary objective of this study was to evaluate the feasibility of MRA-fluoroscopy image fusion using noncontrast CBCT as a guidance tool during complex endovascular aortic procedures, especially in patients with moderate to severe renal insufficiency.
METHODS
This single-center retrospective study included all consecutive patients who underwent an endovascular aortic procedure using MRA-fluoroscopy image fusion guidance technique using intraoperative noncontrast CBCT images. The study was approved by the Houston Methodist Hospital Institutional Review Board. Patient informed consent was not required for the study.
MRA imaging
Our MR protocol is derived from standard, preset, readily available protocols from the MR imaging (MRI) scanner vendors, with slight modification. MRIs were acquired using 1.5 T or 3.0 T MRI scanners (1.5 T MAGNETOM Avanto/3.0 T MAGNETOM Verio; Siemens Healthcare GmbH, Erlangen, Germany) with phasedarray coil systems.
In patients without a contraindication to gadolinium (ie, GFR >30 mL/min/1.73 m 2 ), gadopentetate dimeglumine (Magnevist; Bayer Healthcare, Whippany, NJ) was used to provide blood contrast at a concentration of 0.2 mL/kg. In patients with a contraindication to gadolinium-based contrast agent (GBCA; eg, GFR <30 mL/min/1.73 m 2 , dialysis, or acute kidney disease), infusion of 90 mg of ferumoxytol (Feraheme), diluted in a 1:8 ratio with saline was used (after exclusion of iron overload by laboratory testing and MRI assessment of liver using cardiac T2* imaging) to enhance vascular delineation. Arterial and venous phase first-pass MRA imaging was performed using a 3D gradient echo sequence with typical parameters: in plane resolution, 1.3 to 1.5 mm; slice thickness, 1.5 mm; flip angle, 30 to 40 ; and minimal achievable echo time and repetition time (TR). In addition, w10 minutes after contrast administration, an equilibrium phase, fat saturated, volumetric interpolated breath-hold examination (VIBE) 3D gradient echo sequence was performed with typical parameters: in plane resolution, 1.3 to 1.6 mm; slice thickness, 1.5 mm; flip angle, 10 to 15 ; echo time, 2.1 msec; and TR, 4.4 msec. Because of the lower flip angle and longer TE/TR, the VIBE sequence provides less background suppression and allows better delineation of bony landmarks.
On the day of the procedure, preoperative MRA images were imported from the picture archiving and communication system into the 3D workstation in the operating room and reconstructed in multiplanar reconstruction and 3D volume-rendered formats.
MRA/X-ray fluoroscopy image fusion and live fluoroscopic image guidance
Under general anesthesia and breath-hold, an intraoperative noncontrast CBCT (5 sec DynaCT portrait protocol, syngo DynaCT; Siemens Healthcare) was acquired in our hybrid operating room equipped with a robotic mounted Recommendation: The authors suggest that in patients with renal failure, three-dimensional magnetic resonance angiography-fluoroscopy image fusion may be helpful in reducing contrast medium and performing endovascular aortic repairs. Detailed workflow illustrates the magnetic resonance angiography (MRA)-fluoroscopy image fusion technique using noncontrast cone-beam computed tomography (CT; CBCT) for aortoiliac interventions in patients with renal insufficiency. Gd, Gadolinium. a and b, Preoperative planning involves two-dimensional (2D) and three-dimensional (3D) postprocessing of MRA data sets and electronic marking of vessel ostia, for, for example, left renal artery (yellow arrowhead), centerlines and other relevant landmarks (planned landing zones, aortic bifurcation). Intraoperative imaging involves a (c) 5-second noncontrast CBCT image acquisition under breath-hold and (d) coregistration with the preprocedural MRA data set. e, The image fusion process is automatically initialized based on bony anatomy and manually refined based on alignment of aortic contours and calcifications (red arrows). f, Overlay of vessel ostia and landmarks on fluoroscopy and (g) completion angiogram after stent graft deployment are shown. CO 2 angiography or intravascular ultrasound (IVUS) imaging techniques were used in conjunction, if indicated. C-arm angiography system (Artis zeego, VC14J; Siemens Healthcare). 2D projection X-ray images acquired over 200 C-arm rotation around the patient was reconstructed as CBCT images using dedicated reconstruction algorithms in the 3D workstation (syngo XWP, VB15D; Siemens) at the hybrid operating room (Fig 1) . Typically, T1 VIBE MRIs were selected for image registration because of better spatial resolution, slice thickness, and visualization of bony landmarks. This highresolution MRA data set facilitates better 3D multiplanar and volume-rendered reconstruction and directly affects the accuracy of image fusion and guidance.
ARTICLE HIGHLIGHTS
Noncontrast CBCT images were then coregistered with MRA images using a dedicated software application (syngo Inspace 3D-3D fusion; Siemens Healthcare), followed by appropriate manual refinements using landmarks pertinent to the individual procedure. T1 VIBE MRI sequences were used for image registration mainly because of their isotropic 3D acquisition with better spatial resolution. The initial coregistration was performed after alignment of bony anatomy from T1 VIBE images with noncontrast CBCT. The registration was then refined by manually aligning landmarks, such as vessel contours, calcifications, indwelling stents and catheters, in CBCT with appropriate vessel contours or signal voids in MRA images (Fig 2) . In patients where good-quality subtracted MRA images were available, T1 VIBE sequences were then replaced for further image guidance, provided all of the MR sequences were scanned in the same frame of reference.
After MRA-CBCT image coregistration, depending on the procedure performed, landmarks, such as the ostium or centerline of targeted vessels as well as proximal or distal optimal stent graft landing zones, were electronically marked on the MRA images using a dedicated application (syngo iGuide Toolbox; Siemens Healthcare). These electronically marked landmarks were then projected in real time onto the live intraoperative fluoroscopic images during arterial cannulation and stent graft deployment. It is noteworthy that after image registration, these landmarks from MRA images overlaid on fluoroscopy were updated in real time with changes in C-arm angulations, table movements, and image zoom. The detailed workflow of intraoperative CBCT imaging and image fusion with MRA is illustrated in Fig 1. This CBCT image fusion technology is available on several imaging systems, including floor and ceiling-mounted angiography systems, irrespective of vendor situation.
Evaluation parameters
Quantitative parameters. Patient demographics, including age, sex, procedure type, and preprocedural and postprocedural renal function parameters, were collected. Procedural success was defined as successful deployment of the stent graft, without type I or III endoleak or untoward branch vessel coverage.
Time needed for MRA-CBCT image registration, procedure time, fluoroscopy time, radiation exposure, number of digital subtraction angiography (DSA) images acquired before stent deployment or selective vessel cannulation, and total number of DSA acquisitions were recorded.
Qualitative evaluation of accuracy of image fusion. The accuracy of the electronic landmarks from MRA images overlaid on live fluoroscopy was evaluated by two senior vascular surgeons (J.B., C.F.B.) and a physician scientist (P.C.) by retrospective review of the procedure recordings, using custom developed qualitative scoring, as described earlier. 13 In summary, a score of 0 or 1 was assigned if the guidewire was outside or inside the electronic vessel ostium from MRA, respectively. Similar scores of 0 or 1 were given if the wire was following or not the virtual vessel centerline from MRA. In case of discrepant results among the experts, the images were reviewed together and evaluated again in consensus.
Adjunctive techniques used to decrease the use of iodinated contrast injection during the procedure, such as intravascular ultrasound (IVUS) imaging and carbon dioxide (CO 2 ) angiography, were also recorded. Whenever feasible, IVUS imaging or CO 2 angiography, or both, were also used to validate the accuracy of overlaid electronic landmarks from MRA images before vessel cannulation or device deployment.
RESULTS
Between November 2012 and March 2016, 10 patients (six men), with a mean (6standard deviation for all continuous data) age of 76 6 1.6 years, underwent a complex endovascular aortic procedure using MRA-CBCT image fusion guidance. Procedures included four thoracic endovascular aortic repairs for thoracoabdominal aortic aneurysm in two patients, one thoracic penetrating aortic ulcer, and one chronic type B aortic dissection, five abdominal endovascular aneurysm repairs (EVARs) for infrarenal abdominal aortic aneurysms, and one right internal iliac aneurysm stenting.
Contrast-enhanced MRA was performed with Magnevist in five patients (GFR of 44 6 3.2 mL/min) and with Feraheme in five patients (GFR of 28 6 2.8 mL/min). The creatinine level and GFR before preprocedural imaging were 1.8 6 0.2 mmol/L and 36.0 6 3.4 mL/min, respectively. The postprocedural creatinine level and GFR were 1.8 6 0.2 mmol/L and 37.7 6 3.5 mL/min, respectively. A paired t-test analysis showed no difference between preimaging and postoperative renal function (P ¼ .64 for creatinine level and P ¼ .6 for Table I .
The average time needed for image registration process between preoperative MRA and intraoperative noncontrast CBCT was 4 minutes and 9 seconds 6 1 minute and 31 seconds. All procedures were successful. The mean total fluoroscopy time was 20.1 6 6.9 minutes, and the total procedure time was 1 hour and 51 minutes 6 19 minutes. The mean total radiation dose was 39,873 6 11,654 mGy/m 2 , and the mean radiation dose from CBCT acquisition was 3819 6 348 mGy/m 2 (10% of mean total radiation dose).
Overall, six visceral arteries were cannulated among the 10 procedures, with a mean number of DSAs before vessel cannulation of 0.5 6 0.2. For three vessels, no DSA was performed before cannulation, and navigation was only based on the virtual ostia and centerlines from MRA that were overlaid on the live fluoroscopic image. Fig 3 illustrates the cannulation of a right internal iliac artery performed without any contrast-enhanced DSA acquisition. At the discretion of the primary surgeon, one DSA acquisition was performed before cannulation for the three remaining vessels. The mean number of DSAs before stent graft deployment was 1 6 0.4, and five procedures were performed without any DSA acquisition before stent graft deployment. Mean total number of DSA acquisitions, including CO 2 angiograms acquired during the entire procedure, was 7.8 6 2.
To limit intraoperative use of iodinated contrast injection in seven patients, we used CO 2 DSA or IVUS imaging to verify the location of the ostium of visceral or supra-aortic branches. We used IVUS guidance in four patients. All DSAs in two patients were acquired using CO 2 as the contrast agent (in addition to IVUS imaging for one of them), and iodinated and CO 2 contrast agents were both used for DSA acquisitions in two patients. Fig 4 illustrates the use of IVUS imaging to differentiate the true from the false lumen and to verify the accuracy of the electronic landmarks in fluoroscopy after image fusion.
Quantitative results, such as radiation dose, fluoroscopy time, procedure time, number of DSA acquisitions, and use of IVUS/CO 2 angiography, are summarized in Table II .
Qualitative evaluation of image fusion accuracy. Three experts reviewed the fluoroscopy recordings to evaluate the accuracy of 22 virtual landmarks from MRA images overlaid on live fluoroscopy. For cases with discordant results, the experts reviewed the images in consensus to provide qualitative evaluation. Qualitative results of image fusion accuracy for individual landmarks are summarized in Table III . Of 22 landmarks, 14 (63.6%) were evaluated to be completely accurate (score ¼ 1) compared with the actual ostium, centerline or boundary of the concerned vessel during DSA imaging. The remaining eight landmarks (with score ¼ 0) were readjusted based on the angiography using iodinated contrast or CO 2 injection. Five of the eight (62.5%) incorrect virtual landmarks were due to vessel deformation caused by endovascular devices (wires and catheters) in iliac and visceral arteries.
DISCUSSION
This study reports that image fusion between preoperative 3D MRA and intraoperative 2D fluoroscopy was feasible using intraoperative noncontrast CBCT and provided accurate image guidance for complex endovascular aortic procedures in patients with renal insufficiency. Although there have been earlier reports of MRA image fusion for aortic interventions, [10] [11] [12] renal insufficiency with high risk of acute worsening after an endovascular procedure. 14 However, their renal function has remained throughout the diagnostic and therapeutic process, as evidenced by creatinine and GFR levels in Table I . Given the recent association between nephrogenic systemic fibrosis (NSF) and GBCA, the American College of Radiology recommends avoiding any GBCA in NSF high-risk patients 15 with acute kidney disease, GFR <30 ml/min, and undergoing dialysis. In such cases, iron-based blood pool contrast agents, such as ferumoxytol, have been used as an alternative for contrast-enhanced MRA. 16 Ferumoxytol is a superparamagnetic iron oxide developed as an intravenous iron supplement for patients with anemia of renal failure. It is thus safe for patients with chronic renal disease or at risk for NSF. 17 Tacher et al 12 recently showed the feasibility of MRA image fusion guidance for EVAR in five patients with renal insufficiency or severe contrast allergy. They reported 100% technical success as well, using a similar 3D image fusion technique, but they did not evaluate the accuracy of their image fusion process. Furthermore, they did not use ferumoxytol as the blood pool contrast agent for patients with severe renal insufficiency. Our study not only adds more patients and different types of aortoiliac procedures but also contributes to a better illustration of procedural workflow, complexity of the registration process, including manual refinement techniques, and focuses on qualitative evaluation of accuracy of image-fusion guidance. Image fusion of MRA with fluoroscopy could be technically achieved with 3D-3D or 2D-3D registration techniques; in this study, we adopted only the 3D-3D image registration process. Although the availability of 2D-3D registration techniques simplifies the clinical workflow, it requires additional iodinated contrast injections to achieve vascular alignment, and furthermore, the quantitative accuracy of this technique needs to be validated.
The MRA-CBCT image registration process was technically successful in all patients. In this study, the image registration step was performed by a physician scientist with experience in image fusion. With a mean registration time of 4 minutes and 9 seconds 6 1 minute and 31 seconds, it is a relatively quick process in trained hands, practically achievable during patient preparation without causing procedural delay. Currently available automatic image registration algorithms are based on mutual information-based algorithms optimizing joint histograms from image intensities (primarily contributed by bony anatomy) between CTA and CBCT, resulting in bony landmark alignment that allows good automatic results when CTA is used as the preoperative imaging set. Unfortunately, bones and calcifications do not contribute to a similar intensity range on MRA data sets compared with noncontrast CBCT, and hence other landmarks were used to manually refine the registration process. This study used bony anatomy as the initialization step, and further refinement of the registration process was based on aligning aortic contours, stent grafts, and calcifications seen in noncontrast CBCT and with aortic contours and signal voids from calcifications in MRA images. Fig 2 il lustrates the process of image registration and manual refinement techniques to improve the accuracy of image fusion.
Quantitative validation of accuracy of 3D roadmapping after image fusion is in itself a challenging topic. One of the phantom studies published evaluating the accuracy of 3D roadmapping in the field of interventional neuroradiology reported a 3D-3D registration error of 0.5 mm, and a calibration-based 2D-3D registration error of 0.2 mm. 18 In this study, we evaluated the accuracy of MRA image fusion by qualitatively comparing the accuracy of the virtual marks overlaid on the fluoroscopy screen (vessel ostium, centerlines, landing zones) with actual guidewire trajectories and arteriograms. Our qualitative analysis showed total accuracy (score ¼ 1) of virtual landmarks in 64% (14 of 22) of landmarks from MRA. The remaining landmarks required manual repeat registration of the 3D MRA volume to 2D fluoroscopy, based on angiography. Theoretically, the accuracy of electronic markers from MRA images overlaid on fluoroscopy could be related to one or more of the following technical and clinical factors:
1. Error from 3D-3D image registration step between MRA and CBCT data sets, which can be related to user-defined manual refinement, lower spatial resolution of MRA images, or 3D CBCT geometric calibration error; 2. Error from 2D-3D projection calibration between the 3D MRA dataset and 2D projection fluoroscopic image; 3. Error from inaccurate real-time tracking of C-arm and table movements; 4. Error from patient/cardiac or respiratory movements, or both; or 5. Error from deformation of the vascular anatomy with endovascular wires, sheaths, and devices.
Detailed analyses of accuracy of 2D and 3D errors during image fusion were described earlier for the CTA-CBCT registration process in 16 EVAR patients. 19 Finally, our retrospective qualitative analysis method compared the virtual landmarks with the actual vessel location or trajectory based on a 2D fluoroscopy or angiography image. We have thus no assessment of the 3D orientation of vessels during accuracy evaluation, and any imprecisions in the plane perpendicular to the C-arm projection evaluated may not be captured in this qualitative analysis. At any point of the procedure, the user has the option to readjust the 3D virtual landmarks using manual translation/rotation of MRA based on fluoroscopic image or DSA to account for the errors described above. Because of the retrospective nature of this study, we did not have accurate documentation of the volume of contrast agent used during each procedure step. However, a surrogate estimation of contrast agent used, by counting the number of DSA acquisitions, was reported as published in the earlier literature. 13 Considering the three vessel cannulations and five device deployments that were performed without any prior contrast enhanced DSA and based only on the image-fusion technique, this study illustrates the high clinical value of this image-fusion technique. In our experience, there are three major utilities of the MRA fluoroscopy-image fusion technique:
1. 3D planning of the procedure using vascular information from MRA, and vascular calcification information from intraoperative noncontrast CBCT; 2. Optimization of the C-arm angle for ideal device deployment in aorta or vessel cannulation, or both, based on MRA data after image fusion, to avoid parallax and considering the most recent intraoperative patient orientation; and 3. Overlay of vessel ostia/centerline/planned device landing zone from the MRA on real-time fluoroscopy for image guidance.
After image fusion of T1 VIBE MR with CBCT, subtracted MRA data sets were loaded and reconstructed in 3D volume-rendered technique format, because all MR sequences were acquired in the same image coordinate space. From this subtracted MRA volume, we selected the optimal C-arm angulation that is ideal for branch cannulation or visualization by minimizing parallax. Then, the C-arm system was automatically driven to this optimal projection before further fluoroscopy or DSA imaging. Fig 5 illustrates this use of ideal C-arm angulation computation during EVAR. This feature was used in all cases and was helpful mainly during complex vessel cannulation (superior mesenteric artery, celiac trunk, and internal iliac artery).
Various other means have been described to reduce nephrotoxic contrast injection during endovascular procedures, especially for patients with renal insufficiency. IVUS imaging has been shown to allow even percutaneous coronary interventions without iodinated contrast administration. 20 In our study, IVUS imaging was used to identify the true and false lumen in the patient with chronic aortic dissection and to verify the location of the ostium of the aortic branches in three patients. IVUS imaging is definitely a valuable imaging tool in the setting of renal insufficiency; however, this technique is still limited to 2D evaluation of 3D anatomy and is associated with additional catheter cost to the procedure. CO 2 angiography is also a well-known alternative to reduce nephrotoxic contrast injection. Several reports showed its feasibility and safety during endovascular procedures while protecting residual renal function in patients with pre-existing renal insufficiency. [21] [22] [23] Koutouzi et al 22 described the association of 3D image fusion and CO 2 DSA to further decrease the use of iodinated contrast media, but their image fusion was still done between intraoperative CBCT and preoperative CTA. Of note, CO 2 DSA is still a projection image without 3D information and often requires higher frame rates to image the CO 2 contrast agent with fast diffusion kinetics in the blood that can potentially increase the radiation dose. In our study, CO 2 DSA, in addition to iodinated contrast DSA, was used in two patients, and two patients underwent their endovascular procedure with only CO 2 -guided arteriograms. Thus, in two cases, the combination of diagnostic MRA imaging, 3D image fusion, and CO 2 angiography allowed the management of complex aortic pathology without any use of nephrotoxic iodinated contrast media in our subgroup of patients with severe renal failure. From our preliminary experience, we recommend the use of CO 2 DSA or IVUS imaging in addition to MRA fluoroscopy image fusion, especially when vessel deformation related to endovascular material is suspected. This retrospective study has a few limitations. The small number of patients for >2 years in this study reflects that most patients still undergo CTA imaging more often in outpatient centers for EVAR planning, or in-house after adequate hydration strategies, and repeat MRI was avoided if external CT imaging was available for image fusion. Although MRA noncontrast CBCT image fusion provides additional 3D guidance, it comes at the expense of additional radiation dose for intraoperative CBCT imaging (10% of mean total radiation dose in our study).
Further potential future strategies, such as lower-dose CBCT imaging and direct 2D-3D image registration techniques, could potentially reduce the additional radiation dose required for image fusion but need to be validated in the context of accuracy of image fusion. More importantly, additional technical expertise might be needed for MRA/CBCT image fusion that could be addressed by optimal training of the technologists in 3D image postprocessing techniques.
CONCLUSIONS
Ferumoxytol or gadolinium-enhanced MRA imaging and image fusion with fluoroscopy using noncontrast CBCT is feasible and allows patients with renal insufficiency to benefit from optimal guidance during complex endovascular aortic procedures while preserving their residual renal function. In addition to CO 2 angiography and IVUS imaging, these diagnostic MRA and image fusion techniques are additional valuable image guidance tools to use in this subset of patients. 
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